Bobo Dang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A high-throughput selection system for fast-acting covalent protein drugs.
Journal: Science (New York, N.Y.)
Published: April 02, 2026
Oral Delivery of Semaglutide and Tirzepatide Using Milk-Derived Small Extracellular Vesicles.
Journal: Journal of extracellular biology
Published: September 05, 2025
Discovery of a Serine-Directed Chemical Reaction for Site-Specific Protein Modification via Phage Display Screening.
Journal: Angewandte Chemie (International ed. in English)
Published: July 02, 2025
Optimizing Solid-Phase Protein Synthesis Using CPG-2000 and a Nickel-Cleavable SNAC-tag Linker.
Journal: Organic letters
Published: February 24, 2025
Zfp106 binds to G-quadruplex RNAs and inhibits RAN translation and formation of RNA foci caused by G4C2 repeats.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 23, 2024
A single backbone amide modification method to achieve single site-specific chemical protein conjugation.
Journal: Methods in enzymology
Published: June 17, 2024
Copper assisted sequence-specific chemical protein conjugation at a single backbone amide.
Journal: Nature communications
Published: October 16, 2023
Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants.
Journal: Nature biomedical engineering
Published: June 18, 2023
Identification of SARS-CoV-2 PLpro and 3CLpro human proteome substrates using substrate phage display coupled with protein network analysis.
Journal: The Journal of biological chemistry
Published: February 02, 2023
An enhanced broad-spectrum peptide inhibits Omicron variants in vivo.
Journal: Cell reports. Medicine
Published: January 26, 2023
Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
Journal: Journal of virology
Published: June 23, 2022
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo.
Journal: Cell research
Published: February 04, 2022
Last Updated: 09/26/2026